priorauth_notes
TL2 Regular · Denver, CO, US
Insurance denials and how to read them. The denial letter usually tells you exactly what to submit next.
Joined 21 August 2025 · last posted 5h
69Posts here
2Topics
0Solutions
258Likes received
121Likes given
17Badges
123Days visited
1kPosts read
Most-liked posts
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #16 · Sourcing › Payments · 7 Jul 2026 · 32 likes On Payment method, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Pen dose counters: what a click does and does not guarantee Started this topic · Devices › Pens & autoinjectors · 11 Nov 2025 · 32 likes On the subject in the title: Pen dose counters: what a click does and does not guarantee Working notes rather than a conclusion. Pen dose counters — I have the…
-
Triple agonism: additive, synergistic, or neither? Replied, post #66 · Compounds › Retatrutide · 10 Jul 2025 · 31 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Half-life, steady state, and accumulation worked through Replied, post #50 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 30 likes That is clearer than the version I had in my head. Thank you.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #49 · Evidence › Journal club · 3 Dec 2024 · 29 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #21 · Pharmacology › Pharmacokinetics · 9 Jun 2026 · 28 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. The…
Where this member posts
| Category | Posts | Share |
|---|---|---|
| Compounds | 12 | 17% |
| Sourcing | 9 | 13% |
| Evidence | 9 | 13% |
| Practice | 8 | 12% |
| Nutrition & Training | 5 | 7% |
| Start Here | 4 | 6% |
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 22 Aug 2025 |
| Basic User | bronze | 24 Aug 2025 |
| Read the Guidelines | bronze | 26 Aug 2025 |
| Welcome | bronze | 1 Sep 2025 |
| First Link | bronze | 4 Sep 2025 |
| First Topic | bronze | 7 Sep 2025 |
| First Quote | bronze | 9 Sep 2025 |
| Asked Well | bronze | 14 Sep 2025 |
| Member | bronze | 24 Sep 2025 |
| First Tag | bronze | 16 Oct 2025 |
| Sourced | bronze | 22 Oct 2025 |
| Reader | bronze | 12 Nov 2025 |
| Editor | bronze | 26 Jan 2026 |
| Nice Topic | bronze | 8 Feb 2026 |
| Nice Post | bronze | 9 Feb 2026 |
| Good Post | silver | 17 Apr 2026 |
| Good Topic | silver | 30 May 2026 |